ArticleEJHaem2021
Ruxolitinib is effective in the treatment of a patient with refractory T-ALL.
Sonia Jaramillo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
7 papers cite it
this papercites it
ArticleEJHaem2021
Sonia Jaramillo et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.